WHO ICTRP trial
RCT to evaluate berberine for improving intestinal metaplasia
JPRN-jRCTs031250217 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs031250217 |
|---|---|
| Public title | RCT to evaluate berberine for improving intestinal metaplasia |
| Scientific title | An exploratory randomized controlled trial evaluating the inhibitory effect of berberine on gastric cancer by improving intestinal metaplasia |
| Primary sponsor | Sue Soichiro |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Patients with gastric intestinal metaplasia intestinal metaplasia |
| Interventions | After study enrollment, an upper gastrointestinal endoscopy and biopsy will be performed. If the gastric mucosa has an intestinal metaplasia score of 2 or higher in any site using the Updated Sydney System, intervention (1) or (2) will be… |
| Registration date | Jul 7, 2025 |
| Target size | 30 |
| Registry page | jrct.mhlw.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: